8:00-9:15

Breakfast and Morning walk in the Garden, optional.

9:15-10:00

Plenary Session 4

Patient Reported Outcome Measures (PROMs) in diabetes

Caroline Terwee (Epidemiologist specialised in clinimetrics and principal investigator at Amsterdam University Medical Centers, The Netherlands)

Chair: Petra Elders, Amsterdam UMC, General Practice, The Netherlands

10:00-11:00

Poster Pitches & Boards, session 3: Diabetes complications

Chair: Ina Danquah, Heidelberg University, Heidelberg Institute of Global Health (HIGH), Germany

Max. 2 min. poster pitches in the main hall, followed by ~40 minutes of questions/discussion next to poster boards in reception hall with drinks available

PP&B20

TYPE 2 DIABETES AS A RISK FACTOR FOR NON-HODGKIN LYMPHOMA: THE MULTIETHNIC COHORT

Gertraud Maskarinec, University of Hawaii Cancer Center, United States of America

PP&B21

DIABETES MORTALITY IN GERMANY: ADDITIONAL INSIGHTS FROM GOMPERTZ DISTRIBUTIONS

Oliver Kuß, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Institute for Biometrics and Epidemiology, Germany

PP&B22

TYPE 2 DIABETES MELLITUS AND HEART FAILURE: AUDIT IN THE METROPOLITAN AREA OF BOLOGNA, ITALY.

Dino Gibertoni, University Hospital of Bologna, Research and Innovation Unit, Italy

PP&B23

NORMATIVE THRESHOLDS OF CARDIOVASCULAR AUTONOMIC FUNCTION: THE LOFUS STUDY

Marie MB Christensen, Steno Diabetes Center Copenhagen, Clinical Epidemiology research, Denmark

PP&B24

THE IMPACT OF HBA1C LEVELS ON PERIOPERATIVE OUTCOMES AFTER COLORECTAL CANCER SURGERY: A COHORT STUDY BASED ON REVIEWS OF MEDICAL RECORDS

Erik Becker, Steno Diabetes Center Aarhus, Aarhus University Hospital, Denmark, Denmark

PP&B25

IMPROVING SUSTAINABILITY OF DIABETIC RETINOPATHY SCREENING

John Smith, Queens University Belfast, School of Medicine, Dentistry, Biomedical Science, United Kingdom

PP&B26

THE ADDED VALUE OF ECG ABNORMALITIES IN PREDICTING INCIDENT CARDIOVASCULAR DISEASE RISK FOR PEOPLE WITH TYPE 2 DIABETES: THE HOORN DIABETES CARE SYSTEM COHORT

Peter P. Harms, Amsterdam UMC, General Practice, The Netherlands

PP&B27

OPTIMALISATION OF MEDICATION IN OLDER PATIENTS WITH TYPE 2 DIABETES MELLITUS (OMED2): A PROCESS ANALYSIS OF THE PILOTSTUDY

Marieke T. Blom, Amsterdam UMC, General Practice, The Netherlands

PP&B28

EXTERNAL VALIDATION OF SCORE2-DM USING ROUTINELY COLLECTED HEALTH DATA FROM ELAN

Sukainah Alfaraj, Leiden University Medical Center, Public Health and Primary Care, The Netherlands

11:00-11:30

Tea/coffee break

11:30-12:30

Oral Presentations, session 5: Omics & genetics

Chairs:

Bendix Carstensen, Steno Diabetes Center Copenhagen, Clinical Research, Denmark

Gloria A. Aguayo, Luxembourg Institute of Health, Precision Health, Luxembourg

10 min.  presentations + 5 min. discussion

OP17

ASSOCIATIONS OF TRANSPORTATION NOISE AND NIGHTTIME TEMPERATURE WITH THE METABOLOME OF THE DUTCH ADULT POPULATION: A CROSS-SECTIONAL STUDY

Mirthe Muilwijk, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

OP18

SMOKING-RELATED METABOLIC SIGNATURE AND GENETIC SUSCEPTIBILITY IN RELATION TO TYPE 2 DIABETES

Yuxia Wei, Karolinska Institutet, Sweden

OP19

LONGITUDINAL METABOLITE AND PROTEIN COURSES PRIOR TO DIABETES MELLITUS DIAGNOSIS IN DANISH BLOOD DONORS

Agnete Troen Lundgaard, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Translational Disease Systems Biology, Denmark

OP20

FAMILIAL CO-AGGREGATION AND SHARED GENETICS OF CARDIOMETABOLIC DISORDERS AND TRAITS: DATA FROM THE MULTI-GENERATIONAL LIFELINES COHORT STUDY

Rima D. Triatin, University Medical Center Groningen, Epidemiology, The Netherlands

12:30-13:30

Lunch

13:30-14:30

Poster Pitches & Boards, session 4: Risk factors of diabetes

Chair: Mirthe Muilwijk, , Amsterdam UMC, Epidemiology and Data Science, The Netherlands

Max. 2 min. poster pitches in the main hall, followed by ~40 minutes of questions/discussion next to poster boards in reception hall with drinks available

PP&B29

LIFE-LONG BODY MASS INDEX TRAJECTORIES AND CARDIOMETABOLIC BIOMARKERS-THE DANISH DIET, CANCER, AND HEALTH-NEXT GENERATION COHORT

Jie Zhang, Aarhus University, Department of Public Health, Denmark 

PP&B30

POSTPRANDIAL INFLAMMATORY RESPONSE IN RELATION TO INSULIN RESISTANCE AND INCIDENT TYPE 2 DIABETES IN A MIDDLE-AGED POPULATION WITH OVERWEIGHT

Rory Caitlin Monahan, Leiden University Medical Centre (LUMC), Clinical Epidemiology, The Netherlands

PP&B31

ANTIOXIDANT NUTRIENTS AND RISK OF LADA AND TYPE 2 DIABETES: A SWEDISH
CASE-CONTROL STUDY AND A MENDELIAN RANDOMIZATION ANALYSIS

Anna-Maria Lampousi, Karolinska Institutet, Institute of Environmrntal Medicine, Sweden

PP&B32

HEALTHY FOOD DIVERSITY AND THE RISK OF TYPE 2 DIABETES IN THE EPIC-POTSDAM STUDY

Daniela V. Nickel, German Institute of Human Nutrition (DIfE) Potsdam-Rehbruecke, Molecular Epidemiology, Germany

PP&B33

THE ASSOCIATION BETWEEN DIETARY TOTAL, ANIMAL, AND PLANT-BASED PROTEIN INTAKE AND DEPRESSIVE SYMPTOMS IN DUTCH ADULTS WITH TYPE 2 DIABETES: THE HOORN DIABETES CARE SYSTEM COHORT

Sanne H.M. Kremers, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

PP&B34

SPOUSE BEHAVIORAL COORDINATION AND PHYSIOLOGICAL CO-REGULATION. A SYSTEMATIC REVIEW OF SPOUSE SYNCHRONY STUDIES

Omar Silverman-Retana, Aarhus University / Aarhus University Hospital, Public Health/ Steno Diabetes Center Aarhus, Denmark

PP&B35

LARGE LANGUAGE MODELS VIA AUTOMATED MACHINE LEARNING FOR EPIDEMIOLOGICAL RESEARCH: A CASE STUDY AND METHOD COMPARISON FROM THE BRITISH NATIONAL CHILD DEVELOPMENT STUDY

Rasmus Wibaek, Steno Diabetes Center Copenhagen, Clinical Research, Denmark

PP&B36

SEDENTARY BREAKS AND TIMING OF PHYSICAL ACTIVITY AND RISK OF TYPE 2 DIABETES

Jeroen van der Velde, Leiden University Medical Centre (LUMC), Clinical Epidemiology, The Netherlands

PP&B37

IS THE ASSOCIATION BETWEEN SOCIAL JETLAG AND BMI MEDIATED BY LIFESTYLE? A CROSS-SECTIONAL SURVEY STUDY IN THE GENERAL POPULATION

Emma Bouman, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

PP&B38

THE EFFECT OF TIMING OF ENERGY INTAKE ON GLYCAEMIA AND TYPE 2 DIABETES RISK: SYSTEMATIC REVIEW AND META-ANALYSIS OF HUMAN INTERVENTION STUDIES

Romy Slebe, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

PP&B39

DIETARY PATTERNS AND CARDIOMETABOLIC DISEASES: CAN METABOLOMICS UNRAVEL POTENTIAL MECHANISMS?

Daniel Ibsen, Steno Diabetes Center Aarhus, Denmark

14:30-15:30

Oral Presentations, session 6: Type 1 Diabetes, Youth Onset - Type 2 Diabetes, childhood factors

Chair:

Lasse Bjerg, Aarhus University Hospital, Steno Diabetes Center Aarhus, Denmark

Sabita Soedamah-Muthu, Tilburg University, The Netherlands

4 presentations 15 minutes each (10 min. slides + 5 min. discussion)

OP21

PRENATAL AND ADULT EXPOSURE TO SMOKING AND INCIDENCE OF TYPE 1 DIABETES IN CHILDREN AND ADULTS-A NATIONWIDE STUDY WITH A FAMILY-BASED DESIGN.

Sofia Carlsson, Karolinska Institutet, Institute of Environmental Medicine, Sweden

OP22

PROFILES OF GLYCEMIC CONTROL IN PEOPLE WITH TYPE 1 DIABETES USING CONTINUOUS GLUCOSE MONITORING: A CLUSTERING APPROACH IN THE SFDT1 STUDY

Gloria A. Aguayo, Luxembourg Institute of Health, Precision Health, Luxembourg

OP23

LONGITUDINAL TRAJECTORIES OF FASTING C PEPTIDE IN YOUTH-ONSET TYPE 2 DIABETES

Allison Shapiro, University of Colorado Anschutz Medical Campus, United States of America

OP24

THE IMPORTANCE OF APPETITE AND DIETARY PATTERNS FOR THE ASSOCIATION BETWEEN EARLY-LIFE MALARIA AND FASTING PLASMA GLUCOSE AMONG TEENAGERS IN RURAL GHANA

Mahir Bhatt, Universität Heidelberg, Heidelberg Institute of Global Health, Germany

15:30-16:30

Poster Pitches & Boards , session 5: Diabetes in the mix

Chair: Sofia Carlsson, Karolinska Institutet, Institute of Environmental Medicine, Sweden

Max. 2 min. poster pitches in the main hall, followed by ~40 minutes of questions/discussion next to poster boards in reception hall with drinks available

PP&B40

TYPE 2 DIABETES, THE EPIDEMIC: TRENDS IN INCIDENCE AND PREVALENCE, 2004-2020

Jetty A Overbeek, Amsterdam UMC, General Practice, The Netherlands

PP&B41

- cancelled -

CHANGES IN THE PREVALENCE OF CARDIOVASCULAR RISK FACTORS BETWEEN MEN AND WOMEN IN THE RURAL AND URBAN AREAS OF SOUTHERN INDIA

Arun Nanditha, India Diabetes Research Foundation and Dr.A,Ramachandran's Diabetes Hospitals, , India

PP&B42

PFAS EXPOSURE IN EARLY AND MID-PREGNANCY AND RISK OF GESTATIONAL DIABETES MELLITUS WITHIN THE ETHNICALLY DIVERSE PETALS COHORT

Assiamira Ferrara, Kaiser Permanente Northern California, Division of Research, United States of America

PP&B43

THE ASSOCIATION BETWEEN ALCOHOL CONSUMPTION AND HEART FAILURE WITH REDUCED AND PRESERVED EJECTION FRACTION: THE CARDIOVASCULAR HEALTH STUDY

Anna G. Hoek, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

PP&B44

THE EFFECT OF VITAMIN K SUPPLEMENTATION ON CALCIFICATION PROPENSITY IN INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS: A RANDOMIZED CONTROLLED TRIAL

Romain Meer, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

PP&B45

CARDIOVASCULAR RISK FACTORS ASSOCIATIONS WITH LONG-TERM WEEKLY HEART RATE VARIABILITY IN PREDIABETES – A CROSS-SECTIONAL STUDY FROM THE ADDITION-PRO COHORT

Jonas R. Schaarup, Aarhus University, Department of Public Health, Denmark

PP&B46

EFFECTS OF A 6-MONTHS SUSTAINABLE LIFESTYLE INTERVENTION ON BIOMARKERS OF DIABETES AMONG ADULTS WITH OVERWEIGHT AND OBESITY IN OUAGADOUGOU, BURKINA FASO: A FAMILY-BASED, RANDOMIZED, CONTROLLED TRIAL

Ina Danquah, Heidelberg University, Heidelberg Institute of Global Health (HIGH), Germany

PP&B47

AGGRESSIVE COURSE REQUIRING INSULIN IN YOUTH WITH TYPE 2 DIABETES: 10-YEAR RESULTS FROM THE WORLDWIDE SWEET REGISTRY

Rosaria Gesuita, Università Politecnica delle Marche, Centre of Epidemiology, Biostatistics and Medica Information Technology, Italy

PP&B48

COMPARISON OF GLUCOSE MANAGEMENT INDICATOR WITH HBA1C VALUE IN PATIENTS WITH DIABETES USING CONTINUOUS GLUCOSE MONITORING

Eleftheria Papachristoforou, Laiko General Hospital of Athens, First Department of Propaedeutic Internal Medicine, Greece

PP&B49

FOOD PREFERENCES AMONG GREENLANDERS WITH AN INHERITED INABILITY TO DIGEST SUGAR

Ninna Karsbæk Senftleber, Copenhagen University Hospital, Clinical Research, Steno Diabetes Center Copenhagen, Denmark

PP&B50

INCREASES IN FASTING PLASMA BETA-HYDROXYBUTYRATE CONCENTRATIONS ARE PROPORTIONAL TO WEIGHT LOSS IN ADULTS WITH SEVERE OBESITY UNDERGOING A MEAL REPLACEMENT PROGRAMME.

Francis Martin Finucane, Bariatric Medicine Service, Centre for Diabetes, Endocrinology and Metabolism, Galway University Hospitals, Ireland

16:30-17:00

Tea/coffee break

17:00-18:00

Oral Presentations, session 7: Prediction, AI and other hot themes

Chairs:

Sarah Wild, University of Edinburgh, Usher Institute, United Kingdom

Jessica Edstorp, Karolinska institutet, Institute of Environmental Medicine, Sweden

4 presentations 15 minutes each (10 min. slides + 5 min. discussion)

OP25

VALIDATION OF THE ARIC PREDICTION MODEL FOR SUDDEN CARDIAC DEATH IN AN EUROPEAN POPULATION AMONG PARTICIPANTS WITH DIABETES: THE ESCAPE-NET PROJECT

Marieke T. Blom, Amsterdam UMC, General Practice, The Netherlands

OP26

THE ASSOCIATION BETWEEN CHRONOTYPE AND TOTAL BODY FAT, VISCERAL FAT, LIVER FAT, AND THE INCIDENCE OF TYPE 2 DIABETES

Jeroen van der Velde, Leiden University and Medical Center, Clinical Epidemiology, The Netherlands

OP27

THE MOST IMPORTANT DETERMINANTS OF TYPE 2 DIABETES:  MACHINE LEARNING STUDY USING UK BIOBANK

Moa Lugner, University of Gothenburg, Department of Molecular and Clinical Medicine, Sweden

OP28

OPPORTUNITIES AND CHALLENGES IN GENERATING AND USING TABULAR SYNTHETIC DATA IN EPIDEMIOLOGY: A CASE STUDY FROM THE HEALTH IN CENTRAL DENMARK COHORT

Adam Hulman, Steno Diabetes Center Aarhus, Denmark

18:00-18:15

Closing remarks

Konstantinos Makrilakis (new chair), Femke Rutters

18:15-19:00

Preparation/dressing time

19:00-21:00

Gala dinner including prize ceremony

21:00-00:30

Closing party with live band playing dance music